Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
AmerisourceBergen (ABC) Stock Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
The average price target is $211.14 with a high forecast of $225.00 and a low forecast of $190.00. The average price target represents a 17.31% change from the last price of $179.98.
What is the target price for absci stock? ›| High | $13.00 |
|---|---|
| Low | $6.00 |
| Average | $8.00 |
| Current Price | $3.9000 |
Based on short-term price targets offered by 42 analysts, the average price target for Alphabet comes to $204.00. The forecasts range from a low of $170.00 to a high of $225.00. The average price target represents an increase of 37.18% from the last closing price of $148.71.
What is the target stock price forecast? ›| High | $200.00 |
|---|---|
| Median | $180.00 |
| Low | $119.00 |
| Average | $176.50 |
| Current Price | $151.90 |
A price target is a price at which an analyst believes a stock to be fairly valued relative to its projected and historical earnings. When an analyst raises their price target for a stock, they generally expect the stock price to rise.
What is the stock price forecast for Absci in 2025? ›On average, Wall Street analysts predict that Absci's share price could reach $8.40 by Aug 15, 2025. The average Absci stock price prediction forecasts a potential upside of 108.96% from the current ABSI share price of $4.02.
Is Absci a good company? ›Employees rate Absci 3 out of 5 stars based on 44 anonymous reviews on Glassdoor.
How much will alphabet stock be worth in 5 years? ›Even if Alphabet is trading at 24 times forward earnings after five years, which is equivalent to its five-year average forward price-to-earnings ratio, its stock price could jump to $332 in five years.
What is the 12 month price target for Alphabet? ›Based on analyst ratings, Alphabet Class A's 12-month average price target is $204.21. What is GOOGL's upside potential, based on the analysts' average price target? Alphabet Class A has 35.10% upside potential, based on the analysts' average price target.
Is Alphabet a buy, hold, or sell? ›Alphabet stock has received a consensus rating of buy. The average rating score is and is based on 83 buy ratings, 16 hold ratings, and 0 sell ratings.
What stock has the best forecast? ›
| Ticker | Company | Forecast ROE |
|---|---|---|
| AAPL | APPLE INC | 237.04% |
| MSFT | MICROSOFT CORP | 48.76% |
| NVDA | NVIDIA CORP | 173.14% |
| AMZN | AMAZON COM INC | 46.16% |
1. AltIndex – Overall Most Accurate Stock Predictor with Claimed 72% Win Rate. From our research, AltIndex is the most accurate stock predictor to consider today. Unlike other predictor services, AltIndex doesn't rely on manual research or analysis.
What is the target stock price forecast for 2025? ›According to analysts, TGT price target is 176.50 USD with a max estimate of 200.00 USD and a min estimate of 119.00 USD.
How to predict target price of stock? ›There are many different ways to calculate a price target, but a common method involves using price-to-earnings ratios. If you divide the current P/E by the forward P/E and then multiply by the current price, you should have a reasonable prediction for the price target a year from now.
Can analysts predict stock prices? ›The factors and sources of information to be considered are varied and wide. This makes it very difficult to predict future stock market price behavior. It is evident that stock prices cannot be accurately predicted.
What is a good PE ratio? ›Typically, the average P/E ratio is around 20 to 25. Anything below that would be considered a good price-to-earnings ratio, whereas anything above that would be a worse P/E ratio. But it doesn't stop there, as different industries can have different average P/E ratios.
What is stock target price? ›A target price is an estimate of the future price of a stock. Target prices are based on earnings forecasts and assumed valuation multiples. Target prices can be used to evaluate stocks and may be even more useful than an equity analyst's rating.
What does AbSci do? ›AbSci Corp: Overview
AbSci's technology accelerates drug discovery timelines, increases manufacturing efficiencies and drastically reduces costs for the biopharmaceutical industry. The company provides its proteins and antibodies in the areas of cancer, hormone, autoimmune and blood disorder therapies.
Fair Value Estimate for Target
With its 3-star rating, we believe Target's stock is fairly valued compared with our long-term fair value estimate of $136 per share.
| High | $290.00 |
|---|---|
| Median | $260.00 |
| Low | $203.00 |
| Average | $255.97 |
| Current Price | $255.41 |